Nano-silver – feasibility and challenges for human health risk assessment based on open literature

References

• Ahamed M, Karns M, Goodson M, Rowe J, Hussain SM, Schlager JJ, Hong Y. 2008. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharmacol 233(3):404–410.
   PubMedGoogle Scholar
• Arora S, Jain J, Rajwade JM, Paknikar KM. 2008. Cellular responses induced by silver nanoparticles: In vitro studies. Toxicol. Lett 179(2):93–100.
   PubMed Web of Science ®Google Scholar
• Arora S, Jain J, Rajwade JM, Paknikar KM. 2009. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol Appl Pharmacol 236(3):310–318.
   PubMedGoogle Scholar
• AshaRani PV, Low Kah MG, Hande MP, Valiyaveettil S. 2009. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3(2):279–290.
   PubMed Web of Science ®Google Scholar
• Bar-Ilan O, Albrecht RM, Fako VE, Furgeson DY. 2009. Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small 5(16):1897–1910.
   PubMedGoogle Scholar
• Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. 2005. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicolog Sci 88(2):412–419.
   PubMed Web of Science ®Google Scholar
• Carlson C, Hussain S, Schrand A, Braydich-Stolle L, Hess K, Jones R, Schlager J. 2008. Unique cellular interaction of silver nanoparticles: Size-dependent generation of reactive oxygen species. J Phys Chem B 112:13608–13619.
   PubMed Web of Science ®Google Scholar
• Cha K, Hong HW, Choi YG, Lee MJ, Park JH, Chae HK, Ryu G, Myung H. 2008. Comparison of acute responses of mice livers to short-term exposure to nano-sized or micro-sized silver particles. Biotechnol.Lett 30(11):1893–1899.
   PubMedGoogle Scholar
• Chang ALS, Khosravi V, Egbert B. 2006. A case of argyria development after colloidal silver digestion. J Cutaneous Pathol 33(12):809–811.
   PubMedGoogle Scholar
• Chi Z, Liu R, Zhao L, Qin P, Pan X, Sun F, Hao X. 2009. A new strategy to probe the genotoxicity of silver nanoparticles combined with cetylpyridine bromide. Spectrochim Acta A Mol Biomol Spectrosc 72(3):577–581.
   PubMedGoogle Scholar
• Cho W-S, Cho M, Jeong J, Choi M, Cho H-Y, Han BS, Kim SH, Kim HO, Lim YT, Chung BH, Jeong J. 2009. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 236(1):16–24.
   PubMedGoogle Scholar
• De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJAM, Geertsma RE. 2008. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29(12):1912–1919.
   PubMed Web of Science ®Google Scholar
• Demou E, Peter P, Hellweg S. 2008. Exposure to manufactured nanostructured particles in an industrial pilot plant. Ann Occup Hyg 52(8):695–706.
   PubMedGoogle Scholar
• Drake PL, Hazelwood KK. 2005. Exposure-related health effects of silver and silver compounds: A review. Ann Occup Hyg 49(7):575–585.
   PubMedGoogle Scholar
• EC (European Commission). 2003. Technical Guidance Document in support of Commission Directive 93/67/EEC on Risk Assessment for new notified substances, Commission Regulation (EC) No 1488/94 on Risk Assessment for existing substances and Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market. European Commission, Joint Research Centre. Accessed from the website: http://ecb.jrc.ec.europa.eu/tgd/.
   Google Scholar
• ECHA (European Chemicals Agency). 2008. REACH Guidance on Information Requirements and Chemicals Safety Assessment. European Chemicals Agency. Accessed from the website: http://guidance.echa.europa.eu/
   Google Scholar
• Hsin YH, Chen CF, Huang S, Shih TS, Lai PS, Chueh PJ. 2008. The apoptotic effect of nanosilver is mediated by a ROS- and JNK dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 179(3):130–139.
   PubMedGoogle Scholar
• Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. 2005. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19(7):975–983.
   PubMed Web of Science ®Google Scholar
• Hyun JS, Lee BS, Ryu HY, Sung JH, Chung KH, Yu IJ. 2008. Effects of repeated silver nanoparticles exposure on the histological structure and mucins of nasal respiratory mucosa in rats. Toxicol Lett 182(1–3):24–28.
   PubMedGoogle Scholar
• Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, Chung YH, Kwon IH, Jeong J, Han BS, Shin JH, Sung JH, Song KS, Yu IJ. 2007. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhalat Toxicol 19(10):857–871.
   PubMedGoogle Scholar
• Johnston HJ, Hutchison GR, Christensen FM, Hankin S, Peters S, Stone V. 2010. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol (Epub ahead of print. DOI: 10.3109/10408440903453074).
   Google Scholar
• Kim YS, Kim JS, Cho HS, Rha DS, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu IJ. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 20:575–583.
   PubMed Web of Science ®Google Scholar
• Kim Y, Suh HS, Cha HJ, Kim SH, Jeong KS, Kim DH. 2009. A case of generalised argyria after ingestion of colloidal silver solution. Am J Ind Med 52(3):246–250.
   PubMedGoogle Scholar
• Larese FF, D'Agostin F, Crosera M, Adami G, Renzi N, Bovenzi M, Maina G. 2009. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 255(1–2):33–37.
   PubMedGoogle Scholar
• Lee KJ, Nallathamby PD, Browning LM, Osgood CL, Xu XHN. 2007. In vivo imaging of transport and biocompatibility of single silver nanoparticles in early development of Zebrafish embryos. ACS Nano 1(2):133–143.
   PubMedGoogle Scholar
• Lubick N. 2008. Nanosilver toxicity: Ions, nanoparticles – or both? Environ Sci Technol 42(23):8617.
   PubMedGoogle Scholar
• Luoma SN. 2008. Silver nanotechnologies and the environment: Old problems or new challenges. The Pew Charitable Trusts and the Woodrow Wilson International Center for Scholars.
   Google Scholar
• Mueller NC, Nowack B. 2008. Exposure modeling of engineered nanoparticles in the environment. Environ Sci Technol 42(12):4447–4453.
   PubMedGoogle Scholar
• SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks). 2007. Opinion on the appropriateness of the risk assessment methodology in accordance with the technical guidance documents for new and existing substances for assessing the risks of nanomaterials. Scientific Committee on Emerging and Newly Identified Health Risks. 21–22 June 2007. Accessed from the website: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_010.pdf.
   Google Scholar
• SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks). 2009. Risk assessment of products of Nanotechnologies. Scientific Committee on Emerging and Newly Identified Health Risks. Opinion adopted 19 January 2009. Accessed from the website: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_023.pdf.
   Google Scholar
• Semmler-Behnke M, Kreyling WG, Lipka J, Fertsch S, Wenk A, Takenaka S, Schmid G, Brandau W. 2008. Biodistribution of 1.4- and 18-nm gold particles in rats. Small 4(12):2108–2111.
   PubMed Web of Science ®Google Scholar
• Singh N, Manshian B, Jenkins GJS, Griffiths SM, Williams PM, Maffeis TGG, Wright CJ, Doak SH. 2009. NanoGenotoxicology: The DNA damaging potential of engineered nanomaterials. Biomaterials 30:3891–3914.
   PubMed Web of Science ®Google Scholar
• Soto K, Garza KM, Murr LE. 2007. Cytotoxic effects of aggregated nanomaterials. Acta Biomaterialia 3(3):351–358.
   PubMedGoogle Scholar
• Sonavane G, Tomoda K, Sano A, Ohshima H, Terada H, Makino K. 2008a. In vitro permeation of gold nanoparticles through rat skin and rat intestine: Effect of particle size. Colloids Surfaces. B Biointerfaces 65(1):1–10.
   PubMed Web of Science ®Google Scholar
• Sonavane G, Tomoda K, Makino K. 2008b. Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size. Colloids Surfaces. B Biointerfaces 66(2):274–280.
   PubMed Web of Science ®Google Scholar
• Sung JH, Ji JH, Yoon JU, Kim DS, Song MY, Jeong J, Han BS, Kim J, Kim TS, Chang HK, Lee EJ, Lee JH, Yu IJ. 2008. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal Toxicol 20:567–574.
   PubMed Web of Science ®Google Scholar
• Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Chang HK, Lee JH, Cho MH, Kelman BJ, Yu IJ. 2009. Subchronic inhalation toxicity of silver nanoparticles. Toxicolog Sci 108(2):452–461.
   PubMed Web of Science ®Google Scholar
• Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J. 2001. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 109(4):547–551.
   PubMedGoogle Scholar
• Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. 2006. Silver coated dressing Acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma 60(3):648–652.
   PubMedGoogle Scholar
• Tsai S, Ada E, Isaacs JA, Ellenbecker MJ. 2009. Airborne nanoparticle exposures associated with the manual handling of nanoalumina and nanosilver in fume hoods. J Nanopart Res 11:147–161.
   Web of Science ®Google Scholar
• Vlachou E, Chipp E, Shale E, Wilson YT, Papini R, Moiemen NS. 2007. The safety of nanocrystalline silver dressings on burns: A study of systemic silver absorption. Burns 33(8):979–985.
   PubMed Web of Science ®Google Scholar
• Wadhera A, Fung M. 2005. Systemic argyria associated with ingestion of colloidal silver. Dermatology Online Journal 11(1):12.
   PubMedGoogle Scholar
• Wiwanitkit V, Sereemaspun A, Rojanathanes R. 2009. Effect of gold nanoparticles on spermatozoa. Fertil Steril 91(1):7–8.
   Google Scholar